Correlation Between Intel and Corbus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Intel and Corbus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intel and Corbus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intel and Corbus Pharmaceuticals Holding, you can compare the effects of market volatilities on Intel and Corbus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intel with a short position of Corbus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intel and Corbus Pharmaceuticals.
Diversification Opportunities for Intel and Corbus Pharmaceuticals
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Intel and Corbus is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Intel and Corbus Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corbus Pharmaceuticals and Intel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intel are associated (or correlated) with Corbus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corbus Pharmaceuticals has no effect on the direction of Intel i.e., Intel and Corbus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Intel and Corbus Pharmaceuticals
Given the investment horizon of 90 days Intel is expected to under-perform the Corbus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Intel is 2.04 times less risky than Corbus Pharmaceuticals. The stock trades about -0.07 of its potential returns per unit of risk. The Corbus Pharmaceuticals Holding is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 3,090 in Corbus Pharmaceuticals Holding on August 27, 2024 and sell it today you would lose (1,343) from holding Corbus Pharmaceuticals Holding or give up 43.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Intel vs. Corbus Pharmaceuticals Holding
Performance |
| Timeline |
| Intel |
| Corbus Pharmaceuticals |
Intel and Corbus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Intel and Corbus Pharmaceuticals
The main advantage of trading using opposite Intel and Corbus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intel position performs unexpectedly, Corbus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corbus Pharmaceuticals will offset losses from the drop in Corbus Pharmaceuticals' long position.The idea behind Intel and Corbus Pharmaceuticals Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Corbus Pharmaceuticals vs. Trevi Therapeutics | Corbus Pharmaceuticals vs. Cue Biopharma | Corbus Pharmaceuticals vs. AN2 Therapeutics | Corbus Pharmaceuticals vs. Bioatla |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |